Contrary to our study cohort, Xu et al. reports that the administration of Cisplatin causes an increase of γ-H2AX in pancreatic carcinoma cells in vitro (Xu et al. 2022). The gene discussed is H2AX; the disease is exocrine pancreatic carcinoma.